Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
PHARMAC Initiated,Pneumococcal vaccine (PCV13),"Prevention of IPD, supplemental dose, individuals aged 12 to 59 months",Pneumococcal vaccine (PCV13) (Pneumococcal vaccine (PCV 13)),Options for investment,Community and Hospital,National Immunisation Schedule
